摘要
本文报道采用精制人白细胞干扰素(IFN)治疗30例原发性肝癌(PLC)Ⅲ～Ⅳ期患者。肝动脉结扎直接灌注IFN治疗PLC治疗组的生存期,存活一年以上6.66,6(2/30例),存活半年以上60%(18/30例),存活三个月以上26.6%(8/30例)。平均存活时间为210天。对照组30例,采用肝动脉结扎插管灌注化学药物,氟脲脱氧核苷(FUOR)。结果多数患者出现毒副反应。
Thirty patients suffering from primary liver cancer,staged Ⅲ—Ⅳ,were treated by interferon which was refi ned from human white cells from April 1986 to August 1988. The results of the infusion of interferon after ligation of the hepatic artery on pri- mary liver cancer were as follows:the rate of survival for more than 1 year after opera- tion was 6.66%(2/30);more than 6 months 30%(18/30),and more than 3 months was 26.6%(8/30),The mean survival time was 210 days. In the control group,3 patients were treated with Floxuridine(FUDR).The method of giving chemotherapy was the same as that of the treatment group,but most of the patients were found to show some toxic reactions.
出处
《华西医学》
CAS
北大核心
1991年第1期69-72,共4页
West China Medical Journal
关键词
肝肿瘤
干扰素
肝动脉
Primary liver cancer
Ligation of hepatic artery
Intubation
Interferon refined from human leucocytes
